PRECISIONBIOLOGICS
Menu
↗
PRECISION BIOLOGICS / LOCATIONS

Orthopedic biologics distributor serving Hartford, CT

Precision Biologics is a master distributor supplying Wharton's jelly tissue allografts and extracellular vesicle (exosome) products to licensed orthopedic practices and surgery centers. Every account is verified against a National Provider Identifier before ordering access is granted. The following outlines how orthopedic groups in Hartford typically review a biologics vendor and set up an account.

REGISTRY DATA / CT

Hartford

NPPES registry listings, primary taxonomy, retrieved 2026-10-27

55
Orthopaedic Surgery
55
Source: NPPES NPI Registry ↗

Vendor qualification for orthopedic groups

Orthopedic practices and ambulatory surgery centers evaluating a new biologics supplier typically request a certificate of analysis for the lot under consideration, a donor eligibility summary, and a lot release record confirming the lot cleared third-party sterility testing and internal release criteria before it shipped.

Group practices often assign this review to a compliance officer or practice administrator, separate from the ordering physician.

Account setup and NPI verification

Ordering access is tied to a verified NPI, and the practice designates which staff may place orders once an account is approved. Precision Biologics supports account setup directly, including walking a compliance contact through the documentation available for a given lot.

Shipping and receiving in the Northeast

Cryopreserved Wharton's jelly formats are shipped overnight on dry ice in validated containers and stored at -80 degrees C on arrival; this applies the same way for a clinic in Hartford as it does anywhere else the product is shipped. The lyophilized Wharton's jelly format is shelf-stable and does not require cryogenic storage, which some practices prefer for simpler receiving.

Confirming regulatory posture

Precision Biologics does not advise on clinical use, dosing, or procedures. Exosome products are not approved by the FDA and are generally regulated as biologic drugs, and whether a specific intended use of a Wharton's jelly product meets the minimal-manipulation and homologous-use criteria in 21 CFR 1271.10 is a determination for the practice and its counsel. Orthopedic groups in Connecticut should confirm their own regulatory posture with the Connecticut medical board and legal counsel.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.

FAQ

Frequently asked questions

Is there a Precision Biologics representative who visits Hartford practices in person?+

No. Account management is handled remotely by phone and online, and verification is based on the practice's NPI rather than a territory assignment.

What documentation should our compliance officer request before approval?+

A certificate of analysis, donor eligibility summary, and lot release record are available for the lot in question, along with supplier processing descriptions on request.

How long does cold-chain shipping take to reach a clinic in Connecticut?+

Cryopreserved products ship overnight on dry ice in validated containers; the clinic should move the shipment to its designated storage as soon as it arrives.